Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Find out where to locate no annual fee credit cards that provide rewards. Maximize your earning potential today!
18,735 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Investors are weighing a bold claim: prediction: will lose value for XRP. This article breaks down what could drive X...
AI advances hinge on memory tech. As the world’s top HBM maker becomes accessible to U.S. investors, learn how this s...
Markets are watching the Fed's next move as rate hikes loom. This guide explains how the pattern of interest rates so...
Aurora Innovation saw a dramatic rally in the first half of 2026. This article explores the factors behind the move, ...
PayPal shares surged following unconfirmed reports of a joint takeover bid by Stripe and Advent International, valued...
SpaceX stock stumbled since its IPO has sparked questions about what comes next. By charting historical IPO patterns ...
Intel stock looks beaten in the near term, but long-term possibilities remain. This guide breaks down the factors tha...
Rocket Lab shares hover near $67 as July odds tilt toward downside. This story breaks down what prediction markets be...
Jim Cramer tells CNBC’s Mad Money Investing Club to sell Oracle and avoid liquor stocks, outlining a mix of defensive...
A high-profile insider move can ripple through a stock's story. This article breaks down the C3.ai CEO's $4.2 million...
A major corporate Bitcoin holder expands its BTC stake during a market pullback, widening unrealized losses but under...